Trial Profile
An Open Study to Investigate the Safety and Efficacy of Replenine-VF in Severe Haemophilia B Patients.
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 06 Nov 2021
Price :
$35
*
At a glance
- Drugs Factor IX (Primary)
- Indications Haemophilia B
- Focus Adverse reactions; Therapeutic Use
- Sponsors Bio Products Laboratory
- 06 Oct 2014 New trial record